Table 3 Unadjusted and Adjusted odds ratios for COVID-19 risk factors in the study cohort
SARS-CoV-2 | Unadjusted | Adjusted | ||||
|---|---|---|---|---|---|---|
Negative | Positive | OR (95% CI) | p-value | OR (95% CI) | p-value | |
Age > 60 years | 4 (5) | 33 (25) | 6 (2–18) | 0.001 | ||
Male | 41 (50) | 79 (57) | 1.3 (0.8–2) | 0.3 | ||
Obesity (BMI > 30 kg/m2) | 21 (28) | 48 (36) | 1.5 (0.8–3) | 0.2 | ||
Type 2 Diabetes | 14 (18) | 88 (68) | 10 (5–20) | < 0.001 | 6.4 (3–14) | < 0.001 |
Hypertension | 5 (6) | 48 (35) | 8.2 (3–22) | < 0.001 | 2.07 (0.7–6) | 0.2 |
Rheumatoid Arthritis | 2 (2) | 3 (2) | 0.9 (0.1–5) | 0.9 | 0.9 (0.1–5) | 0.99 |
Chronic Liver Disease | 0 | 1 (1) | 1.8 (0.1–45) | 0.72 | – | – |
Thyroid Disease | 2 (2) | 3 (2) | 0.9 (0.1–5) | 0.9 | 1.7 (0.2–12) | 0.58 |
Epilepsy | 0 | 2 (1) | 3.0 (0.1–64) | 0.48 | – | – |
Chronic Immobilization | 0 | 1 (1) | 1.8 (0.1–45) | 0.72 | – | – |
Asthma | 1 (1) | 9 (6) | 5.6 (0.7–45) | 0.1 | 6.5 (0.7–61) | 0.1 |
Hyperlipidaemia | 0 | 14 (10) | 19.2 (1.1–327) | 0.04 | – | – |
Heart Disease | 0 | 10 (7) | 13.5 (0.8–233) | 0.07 | – | – |
Anaemia | 3 (4) | 0 | 0.08 (0–2) | 0.1 | – | – |
Chronic Kidney Disease | 0 | 5 (4) | 6.8 (0.4–125) | 0.19 | – | – |
Hypertriglyceridemia | 18 (23) | 48 (37) | 2.0 (1–4) | 0.04 | 1.7 (0.8–4) | 0.17 |
Low HDL-Cholesterol | 28 (35) | 106 (82) | 8.1 (4–15) | < 0.001 | 6.1 (3–14) | < 0.001 |